Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.7 |